KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Current Taxes (2016 - 2025)

Historic Current Taxes for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Q3 2025 value amounting to $91.1 million.

  • Jazz Pharmaceuticals' Current Taxes rose 6578.75% to $91.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.1 million, marking a year-over-year increase of 6578.75%. This contributed to the annual value of $18.8 million for FY2024, which is 4652.16% down from last year.
  • Jazz Pharmaceuticals' Current Taxes amounted to $91.1 million in Q3 2025, which was up 6578.75% from $78.6 million recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Current Taxes peaked at $91.1 million during Q3 2025, and registered a low of $3.6 million during Q2 2021.
  • For the 5-year period, Jazz Pharmaceuticals' Current Taxes averaged around $39.8 million, with its median value being $35.1 million (2023).
  • Its Current Taxes has fluctuated over the past 5 years, first crashed by 9348.86% in 2021, then surged by 106509.66% in 2023.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Current Taxes stood at $9.6 million in 2021, then dropped by 19.68% to $7.7 million in 2022, then soared by 354.5% to $35.1 million in 2023, then plummeted by 46.52% to $18.8 million in 2024, then skyrocketed by 385.9% to $91.1 million in 2025.
  • Its Current Taxes was $91.1 million in Q3 2025, compared to $78.6 million in Q2 2025 and $31.8 million in Q1 2025.